Tempus is an industry leader analyzing clinical and molecular data to identify actionable clinical trial options for cancer patients. Through our proprietary trial matching software and methods, we identify relevant, open, and recruiting clinical trials personalized to each patient’s molecular and clinical context.
The TIME Trial Program is a just-in-time network of providers to support rapid patient identification, site activation, and enrollment of select clinical trials. Through the TIME Trial Program, 2,600 oncologists and their patients have unprecedented access to a large portfolio of cutting-edge precision medicine trials.
Learn more by emailing TIMETrial@tempus.com.
OUR PROCESS
30+ unique clinical trials targeting a wide array of biomarkers including FGFR, KEAP1, RET, NOTCH1, ESR1, and MET.
Trial Matching at Tempus
Research-experienced
institutions
Participating
oncologists
Tempus patients match
to a biomarker trial
Cancer patients
annually
Tempus generates, organizes, and analyzes extensive amounts of data through our next-generation sequencing lab, AI-assisted clinical data structuring capabilities, and connectivity with researchers across the network. We support providers in identifying relevant and actionable clinical trials for their patients.
Our proprietary clinical trial matching software enables real-time matches for relevant, open, and recruiting clinical trials. Tempus’ team of trained abstractors manually reviews all protocol-specific inclusion and exclusion eligibility criteria for trials in the TIME Trial Program.
The program is designed to provide access to thousands of physicians and patients to clinical trials and novel therapeutics, no matter where they are.
All sites and sponsors participating in the TIME Trial Program commit to a standard clinical trial agreement, a pre-negotiated budget, and the use of a central IRB. Additionally, Tempus’ dedicated, expert research liaisons support sites and sponsors in streamlining all recruitment and enrollment activities
The entire activation process is designed to take 10 business days, and the site always makes the decision about particular studies for involvement.
Learn more about recent rapid activation success stories in our TIME Tech Spotlight.
Download